New HEAL Collaborative Analysis Reveals 340B Hospitals Increase Hospital Assets While Reducing Patient Care Spending
A new state-by-state analysis released today by HEAL Collaborative provides further insight into how hospitals participating in the 340B program are allocating resources. The study, titled "The 340B Drug Pricing Program by State: How Covered Entities Are Failing to Invest in Patient Care," was conducted by Magnolia Market Access and provides the first detailed look at how hospitals participating in the federal 340B drug discount program are utilizing program revenues at the state level.
